Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Compound Eucommia ulmoides Jiangu Granules in Real-World Use
ChiCTR2400087317Phase 4Recruiting
- Sponsor
- Zhejiang Hospital of Traditional Chinese Medicine
- Start
- Jul 2024
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Compound Eucommia ulmoides Jiangu Granules in knee osteoarthritis (OA), sponsored by Zhejiang Hospital of Traditional Chinese Medicine. Primary endpoint: Adverse events. Started Jul 2024; status: recruiting.
02
Drugs
Compound Eucommia ulmoides Jiangu Granules
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400087317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087317.